LEO Pharma Presents Late-Breaking Phase 3 Delgocitinib Cream Data in Adolescents with Moderate to Severe Chronic Hand Eczema (CHE)

businesswire

LEO Pharma Presents Late-Breaking Phase 3 Delgocitinib Cream Data in Adolescents with Moderate to Severe Chronic Hand Eczema (CHE) – NEWSnet – News… as it used to be

More Press Releases

May 7, 2026

TalentoHC Expands Into Medellín to Connect Latin America’s Innovation Hub with U.S. Organizations

May 7, 2026

Studio City Company Announces Pricing of Senior Secured Notes Offering

May 7, 2026

2026 ESSENCE Festival of Culture® Presented by Coca-Cola® Reveals Night-by-Night Lineup Featuring Babyface, Leon Thomas, Public Enemy and George Clinton & Parliament-Funkadelic with Friends

May 7, 2026

LEO Pharma Presents Late-Breaking Phase 3 Delgocitinib Cream Data in Adolescents with Moderate to Severe Chronic Hand Eczema (CHE)

TalentoHC Expands Into Medellín to Connect Latin America’s Innovation Hub with U.S. Organizations

Studio City Company Announces Pricing of Senior Secured Notes Offering

2026 ESSENCE Festival of Culture® Presented by Coca-Cola® Reveals Night-by-Night Lineup Featuring Babyface, Leon Thomas, Public Enemy and George Clinton & Parliament-Funkadelic with Friends

The Metals Company Announces First Quarter 2026 Corporate Update Conference Call for Thursday, May 14, 2026